Sigma Planning Corp Acquires New Shares in Solventum Co. (NYSE:SOLV)

Sigma Planning Corp bought a new position in Solventum Co. (NYSE:SOLV) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 3,450 shares of the company’s stock, valued at approximately $241,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Deseret Mutual Benefit Administrators bought a new position in Solventum during the second quarter valued at approximately $25,000. Hollencrest Capital Management bought a new position in shares of Solventum during the 2nd quarter valued at $25,000. Partnership Wealth Management LLC acquired a new stake in shares of Solventum in the 2nd quarter valued at $26,000. Richard W. Paul & Associates LLC bought a new stake in Solventum in the second quarter worth $26,000. Finally, Family Firm Inc. acquired a new position in Solventum during the second quarter worth $26,000.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on SOLV shares. BTIG Research assumed coverage on Solventum in a research note on Thursday, September 5th. They set a “neutral” rating for the company. The Goldman Sachs Group boosted their price objective on shares of Solventum from $48.00 to $54.00 and gave the stock a “sell” rating in a research note on Monday, August 12th. Wells Fargo & Company dropped their target price on shares of Solventum from $69.00 to $64.00 and set an “equal weight” rating on the stock in a report on Friday, August 9th. Morgan Stanley boosted their target price on shares of Solventum from $60.00 to $73.00 and gave the stock an “equal weight” rating in a research report on Monday, November 11th. Finally, Stifel Nicolaus assumed coverage on Solventum in a research note on Tuesday, October 8th. They issued a “buy” rating and a $82.00 price objective on the stock. One analyst has rated the stock with a sell rating, eight have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Solventum currently has a consensus rating of “Hold” and a consensus price target of $68.00.

Solventum Trading Down 0.6 %

Solventum stock opened at $67.48 on Friday. The business has a 50 day moving average price of $70.54 and a two-hundred day moving average price of $62.22. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 12 month low of $47.16 and a 12 month high of $96.05.

About Solventum

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.